U.S. flag

An official website of the United States government

Here’s how you know
Here’s how you know

**Official websites use .gov**
A **.gov** website belongs to an official government organization in the United States.

**Secure .gov websites use HTTPS**
A **lock** ( A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Search Query:
			MAIN MENU

																				
              Health Topics
								All Health Topics A-Z
					
													
		

		Asthma


				

															Heart-Healthy Living


				

															High Blood Pressure


				

															Sickle Cell Disease


				

															Sleep Apnea


				

															Information & Resources on COVID-19
																				
              Health Education
								Education Programs and Initiatives
					
													
		

		The Heart Truth®


				

															Learn More Breathe Better®


				

															Blood Diseases and Disorders Education Program


				

															Publications and Resources
																				
              The Science
								Research Focus Areas
					
													
		

		Blood Disorders and Blood Safety


				

															Sleep Science and Sleep Disorders


				

															Lung Diseases


				

															Health Disparities and Inequities


				

															Heart and Vascular Diseases


				

															Precision Medicine Activities


				

															Obesity, Nutrition, and Physical Activity


				

															Population and Epidemiology Studies


				

															Women’s Health


				

															Research Topics


				

															Clinical Trials


				

															All Science A-Z
																				
              Grants and Training
								Grants and Training Home


				

															Policies and Guidelines


				

															Funding Opportunities and Contacts


				

															Training and Career Development
																				
              News and Events
								News and Events Home
					
													
		

		Email Alerts


				

															All News
					
													
		

		NHLBI News


				

															NHLBI in the Press


				

															Research Features


				

															All Events
					
													
		

		Past Events


				

															Upcoming Events
																				
              About NHLBI
								About NHLBI Home
					
													
		

		Mission and Strategic Vision


				

															Leadership


				

															Divisions, Offices and Centers


				

															Advisory Committees


				

															Budget and Legislative Information


				

															Jobs and Working at the NHLBI


				

															Contact and FAQs


				

															NIH Sleep Research Plan
						
						HOME
		Search Text: Home/< Back ToThe Science/Precision Medicine Activities

Precision Medicine Activities
                            

                                                        Precision medicine is an emerging approach to disease prevention and treatment that considers the unique genes and environment of each patient. The ultimate goal of precision medicine is to provide the right treatment at the right time, tailored to a patient’s individual needs.
                                                On this page
                            Research Making a Difference
                                
                                Why It's Important

                                                                    Key Accomplishments
                                
                                Opportunities & Challenges

                                                                    Advancing the Research
                                
                                                                    Related Reading
                    Research Making a Difference
        Research Making a Difference
                                        African Americans with a variant of the APOL1 gene ... have almost twice the risk of cardiovascular disease"
                                        It is the most sweeping — and significant — study ever of cardiovascular disease in African Americans. Now experts with the groundbreaking Jackson Heart Study (JHS) are taking stock of some of the many insights gleaned since the study began in 2000.
                                                            Read more about the JHS.
                        Health professional adminstering a blood pressure reading with a patient in a chair.
    Read more about the JHS.
    
        WHY IT'S IMPORTANT
                The Precision Medicine Initiative, which launched in 2015, is a bold research effort to revolutionize how we improve health and treat disease. A key element of this effort, the National Institutes of Health’s (NIH) *All of Us* Research Program, collects data from 1 million or more people living in the United States to help study a range of health issues and diseases. In 2016, Congress passed the 21st Century Cures Act, which provides additional support for the Precision Medicine Initiative.
                                            More Information
      
	-
		Precision Medicine Activities
    NHLBI’s precision medicine activities, which complement ongoing NIH efforts, are contributing to the evidence that will someday be used to deliver personalized interventions that reduce the burden of heart, lung, blood, and sleep disorders. NHLBI is working with various NIH partners to share data and technical advice to stimulate and coordinate precision medicine research efforts.

NHLBI’s precision medicine activities are poised to leverage the Institute’s long-term investments in biomedical research — such as biospecimen and clinical datasets from NHLBI’s existing large population studies, including the Framingham Heart Study (FHS), Jackson Heart Study (JHS), and Women’s Health Initiative (WHI) — to advance precision medicine for heart, lung, blood, and sleep disorders.

                KEY ACCOMPLISHMENTS
                    NHLBI designed the Trans-Omics for Precision Medicine (TOPMed) program to complement the NIH All of Us Research Program and Precision Medicine Initiative.
          In its initial phase, focused on whole genome sequencing (WGS), the TOPMed program has sequenced nearly 200,000 genomes from diverse populations.
          The second phase of TOPMed is underway to generate a collection of genomic, epigenomic, transcriptomic, proteomic, and metabolomic data.
          Data from these well-phenotyped individuals is used to build molecular profiles associated with health and disease.
          NHLBI partnered with the Foundation for NIH to help researchers identify new, personalized therapies for heart failure with preserved ejection fraction.
    
        OPPORTUNITIES & CHALLENGES
            In 2016, NHLBI released its Strategic Vision, which guides the Institute’s research activities. Many of the objectives, compelling questions, and critical challenges identified in the plan focus on precision medicine. For example, studying basic biology will help us to better define health and understand the earliest origins of disease processes. Our research leverages new technologies and advances in data science to provide insights into the prevention and precise treatment of heart, lung, blood, and sleep disorders. Our research also investigates health differences among populations in order to develop more targeted treatment and prevention strategies and reduce health disparities.
      
                                    More Information
      
	-
		Precision Medicine Activities
    The TOPMed program supports NHLBI’s precision medicine activities by collecting and coupling genomic data and other -omics data. In biology, *-omics* refers to measurable differences or changes in biological molecules, such as genes, metabolites, proteins, and RNA. NHLBI precision medicine activities lead to more research opportunities that further our understanding and improve how we predict, prevent, diagnose, and treat heart, lung, blood, and sleep disorders.

The WGS revealed hundreds of millions of genetic variants. To better understand the impact of the variants on diseases, efforts to collect other omics data from a subset of WGS participants are underway in the second phase of TOPMed. The omics data include DNA methylation, mRNA, protein, and metabolite profiles. More data types, such as single-cell omics, are being considered.

The TOPMed program empowers investigators to pursue their research through:

Discovering biomarkers that increase or decrease the risk of heart, lung, blood, and sleep disorders
	Discovering molecular bases underlying racial and ethnic disparities in the prevalence of some heart, lung, blood, and sleep disorders, such as asthma
	Understanding how environmental factors interact with genes to preserve health or contribute to the risk of heart, lung, blood, and sleep disorders
	Studying molecular phenotypes associated with social determinants of health
	Identifying potential drug targets
	Redefining heart, lung, blood, and sleep disorders or subtypes of these disorders based on molecular signatures instead of current tissue/organ-based approaches to medicine
	Enabling clinical trials to test treatments in a targeted way, such as in patients with specific genetic markers identified in the WGS project, to help develop personalized interventions
	Accelerating systems medicine and emerging precision medicine in order to predict, prevent, diagnose, and treat heart, lung, blood, and sleep disorders based on a patient’s unique genes, environment, and molecular signaturesTo help build -omics data for the TOPMed program, NHLBI reviews applications from researchers interested in contributing samples for TOPMed WGS and other -omics studies. NHLBI is also supporting efforts to develop new ways to analyze -omics data and will work with NIH to present TOPMed data in the NIH Data Commons.

                Advancing the Research
                    
            NHLBI is advancing precision medicine in many ways. Learn about some of NHLBI’s efforts to support research on precision medicine.
      
                                                We Perform Research
                            NHLBI’s******Division of Intramural Research**studies diseases that affect the heart, blood vessels, and lungs and is actively engaged in research relevant to precision medicine activities, such as how genes, environment, and lifestyle contribute to cardiovascular disease and how genes affect response to treatment.
              We Fund Research
                            The research we fund today will help improve our future health. Many NHLBI divisions, such as the **Center for Translation Research and Implementation Science**, the**Division of Cardiovascular Sciences**, the******Division of Blood Diseases and Resources**, and the**Division of Lung Diseases**, are helping fund research to advance NHLBI precision medicine activities for heart, lung, blood, and sleep disorders.
              The Promise of Precision Medicine
                            Through NHLBI’s **Trans-Omics for Precision Medicine (TOPMed) program**, researchers will use data from studies focused on heart, lung, blood, and sleep disorders to better predict, prevent, diagnose, and treat sleep disorders based on a patient’s unique genes, environment, and molecular signatures.
              Empowering Data Science for Scientific Discovery
                            NHLBI’s **BioData Catalyst******is a shared, cloud-based platform and community where scientists can access and work with biomedical research data. While ensuring patient privacy, it provides secure workspaces to share, store, cross-link, and analyze large datasets generated from biomedical and behavioral research, such as the**Trans-Omics for Precision Medicine (TOPMed) Program**, supporting NHLBI’s efforts toward precision medicine.
              Developing Personalized Strategies for Obesity Treatment
                            The **Accumulating Data to Optimally Predict obesity Treatment (ADOPT) Core Measures Project**identified a set of 50 Core Measures, or factors, spanning four domains — behavioral, biological, environmental, and psychosocial — that may influence how people respond to obesity treatments. The ADOPT Project encourages researchers to use these Core Measures consistently in new clinical trials to develop targeted and potentially more effective strategies to treat obesity.
              Providing Tools to Foster Collaborative Research
                            The **PhenX Toolkit**is an online catalog of standard measures of phenotypes and exposures for use in genome-wide association studies and other biomedical research. The toolkit’s standard measures can help researchers collaborate and combine study data to further precision medicine research.
              Providing Data on Genotype and Phenotype Interaction for Precision Medicine Research
                            TOPMed researchers have started releasing Whole Genome Sequencing Project data through the NIH **Database of Genotypes and Phenotypes (dbGaP)**. The dbGaP was developed to archive and distribute data from studies that have investigated the interaction of genotype and phenotype, including all genome-wide association studies supported by NIH.

                                        View all science about 
Precision Medicine Activities
        
                            Related Health Topics
                                    What Is Asthma?
              What Is Sickle Cell Disease?
              High Blood Pressure
            
                RELATED NEWS
A 3D image of a heart is shown.
              December 14, 2022|
						Research Feature
                                    	
	Accelerating heart failure research
	

        
        An NIH-supported research partnership aims to transform heart failure research to bring personalized therapies to patients Every minute of every day the heart pumps about five quarts of blood – nearly 20 glassfuls – throughout the body. But when changes occur, such as the heart becoming weak or not filling adequately with blood, it loses its... Back To Top Link
  

        

        Back to top
  Web Policies & Notices
  

        

              Accessibility
                      No FEAR Act Data
                      Privacy Policy
                      Freedom of Information Act (FOIA)
                      HHS Vulnerability Disclosure
    
          Related Government Websites
  

        

              Health and Human Services
                      National Institutes of Health
                      Office of the Inspector General
                      USA.gov
    
          Stay Connected
    
      
            chat bubblesLive ChatLive Chat with us, Monday through Friday, 8:30 a.m. to 5:00 p.m. EST.envelopeGet Email AlertsReceive automatic alerts about NHLBI related news and highlights from across the Institute.
  Footer Bottom
  

        



Contact Us
                            Site Index
                            Jobs